Optimizing psychedelic compounds for neuropsychiatric therapy
Neuropsychopharmacology April 5, 2021 Peer reviewed DOI: 10.1038/s41386-021-01004-7 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
- Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome ACS Medicinal Chemistry Letters • August 15, 2025 • via OpenAlex
- Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings Brain and Behavior • July 1, 2025 • via OpenAlex
- Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study Journal of Psychoactive Drugs • June 23, 2025 • via OpenAlex
- Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs Frontiers in Psychology • May 28, 2024 • via OpenAlex